Search research articles
Contact Us
Filters
Showing results (251-260 of 299) with videos related to
Page
of 30
Sort By:
Nature Medicine
|
October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Viruses
|
March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors
Francisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
The Journal of Infectious Diseases
|
October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany
Stephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Iscience
|
February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
The EMBO Journal
|
July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection
Jyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Iscience
|
August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Immunity
|
November 13, 2012
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
Philipp Yu, Wolger Lübben, Heike Slomka, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 299) with videos related to
Sort By:
Page
of 30
Nature Medicine
|
October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Viruses
|
March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors
Francisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
The Journal of Infectious Diseases
|
October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany
Stephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Iscience
|
February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
Meryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
The EMBO Journal
|
July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection
Jyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
The Journal of Infectious Diseases
|
April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
Anindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Iscience
|
August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
Leonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
The Journal of Infectious Diseases
|
November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
Joseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Immunity
|
November 13, 2012
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
Philipp Yu, Wolger Lübben, Heike Slomka, et al.
Page
of 30